Skip to main content
 

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member Company was granted an unique dual clearance from the FDA for the AI detection of
life-threatening cardiac conditions, including heart attacks.

Learn more here.

More News

  • NextGen Invent Joins Innovators’ Network at American Heart Association® Center for Health Technology & Innovation

  • PharmaSmart Joins American Heart Association Innovators’ Network to Advance Evidence-Based Chronic Disease Screening and Community Health Technology & Innovation

  • How AI tools can enable more proactive care